Back

Modular Medical gets FDA clearance for Pivot insulin system software upgrades

Verifying
  • Modular Medical received FDA clearance for Pivot insulin delivery system software enhancements.
  • Shares rose 6.94% to $3.70 in Thursday’s premarket trading, according to Benzinga Pro data.
  • Modular Medical began commercialization preparations across five U.S. markets for October 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.